All individual numbers are from the SEC provided Financial Statement and Notes Data Sets. No guarantee is made for their accuracy. This report only shows the values that are common to a significant number of companies.
AUTONOMIX MEDICAL, INC. Last Reported: 2/29/2024 Stock Symbol: AMIX

Business Address

21 WATERWAY AVENUE, SUITE 300

THE WOODLANDS , TX US 77380

Mailing Address

21 WATERWAY AVENUE, SUITE 300

THE WOODLANDS , TX US 77380
Phone Number: 832-277-7816 / State Incorporated: DE / Fiscal Year End 3 /31

Balance Sheet

Date 12/31/2023 11/30/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022 6/30/2022 3/31/2022
Cash and Cash Equivalents -- -- -- -- -- -- -- -- --
Accounts Receivable Net Current -- -- -- -- -- -- -- -- --
Inventory -- -- -- -- -- -- -- -- --
Prepaid Expenses and Other Current Assets -- -- -- -- -- -- -- -- --
Total Current Assets $1,685,000.00 -- -- -- $865,000.00 -- -- -- --
Property Plant and Equipement $14,000.00 -- -- -- -- -- -- -- --
Intangible Assets Net -- -- -- -- -- -- -- -- --
Goodwill -- -- -- -- -- -- -- -- --
Other Assets -- -- -- -- -- -- -- -- --
Total Assets $1,809,000.00 -- -- -- $865,000.00 -- -- -- --
Accounts Payable $663,000.00 -- -- -- $173,000.00 -- -- -- --
Accrued Liabilities $310,000.00 -- -- -- $48,000.00 -- -- -- --
Total Current Liabilities $7,404,000.00 -- -- -- $221,000.00 -- -- -- --
Long Term Debt $1,457,000.00 -- -- -- -- -- -- -- --
Additional Paid-in Capital -- -- -- -- -- -- -- -- --
Accumulated Other Comprehensive Loss -- -- -- -- -- -- -- -- --
Accumulated Deficit $-33,561,000.00 -- -- -- $-23,543,000.00 -- -- -- --
Total Stockholders' Equity $-5,595,000.00 -- $-2,924,000.00 $2,619,000.00 $644,000.00 $626,000.00 $1,170,000.00 $1,618,000.00 $1,959,000.00
Controlling Interest in Subsidiaries -- -- -- -- -- -- -- -- --
Total Liabilities and Equity $1,809,000.00 -- -- -- $865,000.00 -- -- -- --

Statement of Operations

Date 12/31/2023 11/30/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022 6/30/2022 3/31/2022
Total Revenues -- -- -- -- -- -- -- -- --
Cost of Revenues -- -- -- -- -- -- -- -- --
Gross Profit -- -- -- -- -- -- -- -- --
Research and Development $1,384,000.00 -- -- -- -- $338,000.00 -- -- --
Selling, General, and Administrative -- -- -- -- -- -- -- -- --
Total Operating Expenses $9,614,000.00 -- -- -- -- $1,333,000.00 -- -- --
Loss from Operations $-2,924,000.00 -- -- -- -- $-1,333,000.00 -- -- --
Loss Before Income Taxes $-10,018,000.00 -- -- -- -- $-1,333,000.00 -- -- --
Earnings Per Share Basic $-0.74 -- -- -- -- $-0.11 -- -- --
Weighted Average Shares Basic 13,799,170 -- -- -- -- 11,999,071 -- -- --
Earnings Per Share Diluted $-0.74 -- -- -- -- $-0.11 -- -- --
Weighted Average Shares Diluted 13,487,444 -- -- -- -- 11,999,071 -- -- --
Common Stock Shares Authorized 500,000,000 500,000,000 -- -- 25,000,000 -- -- -- --
Common Stock Shares Outstanding 14,430,221 -- -- -- 12,336,571 -- -- -- --
Common Stock Value $14,000.00 -- -- -- $12,000.00 -- -- -- --
Common Stock Par Or Stated Value Per Share $0.00 $0.00 -- -- $0.00 -- -- -- --
Payments Of Dividends Common Stock -- -- -- -- -- -- -- -- --
Preferred Stock Shares Authorized 10,000,000 10,000,000 -- -- 7,100,000 -- -- -- --
Preferred Stock Shares Outstanding -- -- -- -- -- -- -- -- --
Preferred Stock Value -- -- -- -- -- -- -- -- --
Preferred Stock Par Or Stated Value Per Share $0.00 $0.00 -- -- $0.00 -- -- -- --
Share Price -- -- -- -- -- -- -- -- --
Copyright 2024 PursePoor.com